# TRAVERE THERAPEUTICS, INC. (TVTX) FY2026 Q2 Balance Sheet

- Company: TRAVERE THERAPEUTICS, INC. (TVTX)
- Period: As of 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-08-04, accession number 0001438533-26-000063
- Page: https://plicit.ai/financials/tvtx/fy2026-q2-balance-sheet
- Chart image: https://plicit.ai/charts/tvtx-fy2026-q2-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

- **Assets**: 799,360,000 US dollars
- **Current assets**: 615,141,000 US dollars
- **Non-current assets**: 184,219,000 US dollars
- **Liabilities**: 774,838,000 US dollars
- **Current liabilities**: 152,025,000 US dollars
- **Non-current liabilities**: 622,813,000 US dollars
- **Equity**: 24,522,000 US dollars
- **Marketable debt securities, at fair value**: 371,442,000 US dollars
- **Cash and cash equivalents**: 117,735,000 US dollars
- **Accounts receivable, net**: 80,636,000 US dollars
- **Prepaid expenses and other current assets**: 37,493,000 US dollars
- **Inventory**: 7,835,000 US dollars
- **Intangible assets, net**: 131,518,000 US dollars
- **Long-term inventory**: 32,214,000 US dollars
- **Operating lease right of use assets**: 8,745,000 US dollars
- **Other assets**: 8,511,000 US dollars
- **Property and equipment, net**: 3,231,000 US dollars
- **Accrued expenses**: 136,267,000 US dollars
- **Accounts payable**: 7,495,000 US dollars
- **Operating lease liabilities, current portion**: 6,163,000 US dollars
- **Other current liabilities**: 2,100,000 US dollars
- **Convertible debt**: 602,781,000 US dollars
- **Other non-current liabilities**: 12,071,000 US dollars
- **Operating lease liabilities, less current portion**: 7,961,000 US dollars
- **Additional paid-in capital**: 1,570,242,000 US dollars
- **Common stock $0.0001 par value; 200,000,000 shares authorized; 94,174,767 and 90,922,868 issued and outstanding as of June 30, 2026 and December 31, 2025, respectively**: 9,000 US dollars
- **Preferred stock $0.0001 par value; 20,000,000 shares authorized; no shares issued and outstanding as of June 30, 2026 and December 31, 2025**: 0 US dollars
- **Accumulated deficit**: negative 1,544,612,000 US dollars
- **Accumulated other comprehensive loss**: negative 1,117,000 US dollars
- **Gross equity (calculated)**: 1,570,251,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.